International audienceBACKGROUND: Treatment of ascitic cirrhosis requires monitoring of blood biochemistry. A direct measure of ascites could simplify the medical procedure. We aimed to assess the correlation of sodium (Na), potassium (K), chloride (Cl), urea (U), and creatinine (Creat) in ascitic fluid and venous blood. METHODS: Ascitic fluid and venous blood samples were collected simultaneously from 70 cirrhotic patients. Na, K, Cl, U, and Creat were measured in all samples using a biochemical auto-analyzer. RESULTS: Results are expressed as the mean and SD of 200 concomitant samples of ascitic fluid and venous blood (mmol/L for Na, K, and Cl; g/L for U; mg/L for Creat). In ascites and blood the results were, respectively: 133.1+/-6.6 an...
In this study the concentrations of sodium, potassium and chloride in the ascites fluid, serum and u...
BACKGROUND/AIMS: Aldosterone antagonists are the diuretics of first choice in the treatment of cirrh...
Ascites develops in 5–10% of patients with compensated cirrhosis per year and carries an ominous pr...
AbstractIntroductionThe “spot” urine sodium/potassium (Na/Ku) ratio is a convenient tool to identify...
Introduction: Large-volume paracentesis is one of the usual treatments for cirrhotic patients with t...
To verify prospectively the usefulness of the furosemide-induced natriuresis test in predicting asci...
Medical treatment of cirrhotic ascites is essentially supportive, dictated by the patient's discomfo...
The pathogenesis of salt and water retention in cirrhosis remains unclear. Systemic and portal hemod...
Ascites is the most common cause of decompensation in cirrhosis, and 5% to 10% of patients with comp...
SUMMARY The intracellular sodium, potassium, and water content of isolated leucocytes was estimated ...
Low serum sodium concentration is an independent predictor of mortality in patients with cirrhosis, ...
Includes bibliographical references and index.Experimental models of cirrhosis and ascites / Joan Cl...
Objective. Development of ascites in patients with liver cirrhosis is an ominous sign with a poor ou...
The formation of ascites and edema by patients with chronic liver disease can be controlled by rigid...
Using multiple regression analysis, we have evaluated the clinical and hormonal conditions associate...
In this study the concentrations of sodium, potassium and chloride in the ascites fluid, serum and u...
BACKGROUND/AIMS: Aldosterone antagonists are the diuretics of first choice in the treatment of cirrh...
Ascites develops in 5–10% of patients with compensated cirrhosis per year and carries an ominous pr...
AbstractIntroductionThe “spot” urine sodium/potassium (Na/Ku) ratio is a convenient tool to identify...
Introduction: Large-volume paracentesis is one of the usual treatments for cirrhotic patients with t...
To verify prospectively the usefulness of the furosemide-induced natriuresis test in predicting asci...
Medical treatment of cirrhotic ascites is essentially supportive, dictated by the patient's discomfo...
The pathogenesis of salt and water retention in cirrhosis remains unclear. Systemic and portal hemod...
Ascites is the most common cause of decompensation in cirrhosis, and 5% to 10% of patients with comp...
SUMMARY The intracellular sodium, potassium, and water content of isolated leucocytes was estimated ...
Low serum sodium concentration is an independent predictor of mortality in patients with cirrhosis, ...
Includes bibliographical references and index.Experimental models of cirrhosis and ascites / Joan Cl...
Objective. Development of ascites in patients with liver cirrhosis is an ominous sign with a poor ou...
The formation of ascites and edema by patients with chronic liver disease can be controlled by rigid...
Using multiple regression analysis, we have evaluated the clinical and hormonal conditions associate...
In this study the concentrations of sodium, potassium and chloride in the ascites fluid, serum and u...
BACKGROUND/AIMS: Aldosterone antagonists are the diuretics of first choice in the treatment of cirrh...
Ascites develops in 5–10% of patients with compensated cirrhosis per year and carries an ominous pr...